Management of Postpartum Eclampsia

First-Line Treatment

• Magnesium sulfate is the first-line treatment for postpartum eclampsia, administered as a 4-5g IV loading dose followed by continuous infusion or intermittent IM dosing, and should be continued for 24 hours postpartum, as recommended by the American College of Obstetricians and Gynecologists 1

Concurrent Blood Pressure Management

• The European Society of Cardiology recommends treating blood pressure ≥160/110 mmHg lasting >15 minutes immediately with antihypertensive agents 3
• First-line agents for acute severe hypertension include IV labetalol, oral nifedipine, and IV hydralazine, according to the European Heart Journal 3
• The American Heart Association recommends maintaining systolic BP <160 mmHg and diastolic BP <110 mmHg to prevent cerebrovascular complications 3

Postpartum Monitoring Protocol

• The American College of Obstetricians and Gynecologists recommends monitoring BP at least every 4-6 hours while awake for a minimum of 3 days postpartum 2
• Repeat hemoglobin, platelets, creatinine, and liver transaminases the day after delivery, and continue every second day until stable if abnormal before delivery, as suggested by the American College of Obstetricians and Gynecologists 2

Common Pitfalls to Avoid

• The American College of Obstetricians and Gynecologists advises against using NSAIDs like ibuprofen in postpartum preeclampsia patients with renal disease, AKI, placental abruption, sepsis, or postpartum hemorrhage, and recommends using acetaminophen instead 4
• The American Heart Association recommends not discharging patients before 24 hours postpartum or until vital signs are stable 5

Follow-Up Requirements

• The American College of Obstetricians and Gynecologists recommends reviewing all women at 3 months postpartum to ensure BP, urinalysis, and laboratory tests have normalized 2
• Refer women with persistent hypertension or proteinuria at 6 weeks to a specialist, and counsel about 15% recurrence risk in future pregnancies and increased lifetime cardiovascular disease risk, as suggested by the American College of Obstetricians and Gynecologists 2